These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 26496381)
1. Getting it right: 3D cell cultures for the assessment of photosensitizers for photodynamic therapy. Senge MO; Stafford S Future Med Chem; 2015; 7(15):1957-60. PubMed ID: 26496381 [No Abstract] [Full Text] [Related]
2. Recent Advances in Developing Photosensitizers for Photodynamic Cancer Therapy. Chen C; Wang J; Li X; Liu X; Han X Comb Chem High Throughput Screen; 2017; 20(5):414-422. PubMed ID: 28088891 [TBL] [Abstract][Full Text] [Related]
3. Organic/inorganic nanohybrids rejuvenate photodynamic cancer therapy. Liang C; Zhang X; Wang Z; Wang W; Yang M; Dong X J Mater Chem B; 2020 Jun; 8(22):4748-4763. PubMed ID: 32129418 [TBL] [Abstract][Full Text] [Related]
5. Light-enhanced hypoxia-responsive nanoparticles for deep tumor penetration and combined chemo-photodynamic therapy. Li Z; Wu M; Bai H; Liu X; Tang G Chem Commun (Camb); 2018 Nov; 54(93):13127-13130. PubMed ID: 30398488 [TBL] [Abstract][Full Text] [Related]
7. Combination of PDT photosensitizers with NO photodononors. Fraix A; Sortino S Photochem Photobiol Sci; 2018 Nov; 17(11):1709-1727. PubMed ID: 30141820 [TBL] [Abstract][Full Text] [Related]
8. A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib. Zhang FL; Huang Q; Zheng K; Li J; Liu JY; Xue JP Chem Commun (Camb); 2013 Oct; 49(83):9570-2. PubMed ID: 24018863 [TBL] [Abstract][Full Text] [Related]
9. Current clinical and preclinical photosensitizers for use in photodynamic therapy. Detty MR; Gibson SL; Wagner SJ J Med Chem; 2004 Jul; 47(16):3897-915. PubMed ID: 15267226 [No Abstract] [Full Text] [Related]
10. Biophysical Characterization and Anticancer Activities of Photosensitive Phytoanthraquinones Represented by Hypericin and Its Model Compounds. Verebová V; Beneš J; Staničová J Molecules; 2020 Dec; 25(23):. PubMed ID: 33271809 [TBL] [Abstract][Full Text] [Related]
11. A comprehensive tutorial on in vitro characterization of new photosensitizers for photodynamic antitumor therapy and photodynamic inactivation of microorganisms. Kiesslich T; Gollmer A; Maisch T; Berneburg M; Plaetzer K Biomed Res Int; 2013; 2013():840417. PubMed ID: 23762860 [TBL] [Abstract][Full Text] [Related]
12. Designing red-light-activated multifunctional agents for the photodynamic therapy. Higgins SL; Brewer KJ Angew Chem Int Ed Engl; 2012 Nov; 51(46):11420-2. PubMed ID: 23055391 [No Abstract] [Full Text] [Related]
13. Editorial: Throwing Light on Recent Advances on Metallodrugs: From Deemed Poisons to a Striking Hope for the Future. Nardon C; Fregona D Curr Med Chem; 2018 Feb; 25(4):434-436. PubMed ID: 29494325 [No Abstract] [Full Text] [Related]
14. Combining Inorganic Chemistry and Biology: The Underestimated Potential of Metal Complexes in Medicine. Karges J Chembiochem; 2020 Nov; 21(21):3044-3046. PubMed ID: 32896976 [TBL] [Abstract][Full Text] [Related]
15. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. O'Connor AE; Gallagher WM; Byrne AT Photochem Photobiol; 2009; 85(5):1053-74. PubMed ID: 19682322 [TBL] [Abstract][Full Text] [Related]